The Pharma Data

NOVEMBER 5, 2020

For the first time, the world has rallied behind a plan to accelerate the development of the vaccines, diagnostics and therapeutics we need, and to ensure they are available to all countries on the basis of equity. The Access to COVID-19 Tools (ACT) Accelerator is delivering real results.

International 52

International Compliance Virus Vaccine 52

The Pharma Data

NOVEMBER 16, 2020

HPV vaccination, screening and treatment for cervical pre-cancer and cancer, which are critical to preventing and managing cervical cancer are yet to be fully scaled up, contributing. care by 2030. care by 2030. choice and improving access to vaccination for girls and screening and treatment for women is critical.

Vaccine 52

Vaccine Treatment Virus 52

The Pharma Data

DECEMBER 1, 2020

Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 was endorsed by the Seventy-third World Health Assembly last week. She said achieving the 2030 goals will happen only with collaboration and coordination across sectors, with strong country ownership.

Disease 52

Disease Vaccine Government Science 52

The Pharma Data

SEPTEMBER 30, 2021

Today on World Rabies Day, we commemorate the death of Pasteur who developed the primary rabies vaccine, laying the foundations for rabies prevention. The COVID-19 pandemic has resulted in an upsurge of anti-vax and anti-science movements, yet vaccination and awareness can save lives.

Vaccine 52

Vaccine Government Disease International 52

The Pharma Data

NOVEMBER 16, 2020

WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Meeting the following targets by 2030 will place all countries on the path toward elimination: 90% of girls fully vaccinated with the HPV vaccine by 15 years of age.

Vaccine 40

Vaccine Treatment Disease Engineering 40

The Pharma Data

OCTOBER 28, 2021

billion (up 10.1%) due to strong growth from Dupixent ® , Vaccines and CHC. Vaccines up16.5, with record daily deals driven by discerned flu vaccines and meningitis ballot recovery. We help illness with vaccines, give innovative treatments to fight pain and ease suffering. Q3 2021 sales grew double digit to €10.4

Vaccine 52

Vaccine Treatment Drugs 52

The Pharma Data

MAY 5, 2022

Using donations, partnerships and collective action, Foundation S will focus on three critical areas: childhood cancer, the health of communities most vulnerable to the effects of climate change and pollution, and access to lifesaving medicines and vaccines. Vanina Laurent-Ledru will lead Foundation S.

Vaccine 52

Vaccine Treatment Hospitals International 52

DrugBank

NOVEMBER 4, 2024

trillion loss in GDP by 2030 shows the urgency of this crisis.  A study from Oxford University demonstrated that in 2019, 1.27 million deaths were directly attributable to antibiotic resistance, with another 4.95 million deaths associated with it. The World Bank' s projection of a potential $3.4

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Government DNA 98

Codon

MARCH 24, 2024

market with Wegovy will, by 2030, require about one million liters of production capacity. MenAfriVac is a meningococcal vaccine that remains active, without refrigeration, for up to four days and has significantly boosted vaccine coverage in parts of sub-Saharan Africa. We further estimate that supplying just the U.S.

Engineering 87

Engineering Vaccine Production RNA 87

The Pharma Data

APRIL 22, 2023

Since 1997, WHO and UNICEF have jointly collected information on immunization programmes and vaccine-preventable diseases. In 2020, WHO Member States endorsed the Immunization Agenda 2030 (IA2030), where eJRF data is used to report on the monitoring and evaluation framework that guides immunization strategies at global and regional levels.

Vaccine 40

Vaccine Disease 40

NIH Director's Blog: Drug Development

MAY 15, 2018

So, researchers have been searching the genome of Plasmodium falciparum , the most-lethal species of the malaria parasite, for potentially better targets for drug or vaccine development. That list of 2,680 essential genes now becomes an important starting point for future research as well as drug and vaccine development.

Drug Development 52

Drug Development Drugs Disease Treatment 52

The Pharma Data

NOVEMBER 11, 2021

By 2030, we aim to impact the lives and health of 50 million people and engage 20,000 Boehringer Ingelheim employees, through supporting social entrepreneurs in vulnerable communities.”. Today marks the inaugural start of the “Making More Health Together 2021″ convention.

Vaccine 40

Vaccine Therapies Marketing Research 40

PerkinElmer

JANUARY 25, 2023

There is a strong will to increasing the number of newborns screened for sickle cell disease (SCD) from its current level of 4% to 50% by 2030. Big, bold commitments such as these will hopefully continue in the year ahead. Furthermore, technological improvements will be a driving force behind future advances in NBS globally.

Science 52

Science Laboratories Immune Response Disease 52

The Pharma Data

APRIL 27, 2021

at CER driven by growth drivers Dupixent ® and Vaccines. Vaccines up 5.3%, driven by PPH franchise and demand for influenza vaccines in southern hemisphere. Vaccines delivered growth in its core segments. Polio/Pertussis/Hib vaccines (incl. Influenza vaccines (incl. Meningitis/Pneumo vaccines (incl.

Vaccine 52

Vaccine Production FDA Disease 52

The Pharma Data

SEPTEMBER 15, 2020

Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatment. The World Health Organization has set goals for countries to take action to eliminate cervical cancer by 2030. Nat Rev Dis Primers.

FDA Approval 52

FDA Approval FDA Laboratories Disease 52

The Pharma Data

FEBRUARY 8, 2021

Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. We continue to work in parallel on our two COVID-19 vaccine candidates, with clinical trials starting in the coming weeks.

Vaccine 52

Vaccine Production FDA Therapies 52

The Pharma Data

FEBRUARY 4, 2021

Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. We continue to work in parallel on our two COVID-19 vaccine candidates, with clinical trials starting in the coming weeks.

Vaccine 52

Vaccine Production FDA Therapies 52

The Pharma Data

MAY 4, 2021

” “Even as the world makes progress on vaccine roll-outs, it remains vital for treatments to be available that can make a meaningful difference for those fighting COVID-19,” said David A. Ricks , Lilly chairman and CEO. It was identified from a blood sample taken from one of the first U.S.

Therapies 52

Therapies Hospitals Treatment FDA Approval 52

The Pharma Data

MARCH 11, 2021

Sustainability forms an integral part of Bayer’s business strategy, growth plans and incentive systems, Baumann stressed, citing as an example the company’s decision to become carbon-neutral by 2030. Speeding up sales growth. Sales growth at Bayer is planned to regain momentum in 2021 and further accelerate in the years thereafter.

Science 52

Science Pharmaceuticals Licensing Licensing 52

The Pharma Data

JANUARY 9, 2021

• Anthrax Vaccines. Anthrax vaccine revenues are expected to be at a more normalized annual level and continue to primarily reflect procurement of AV7909 (Anthrax Vaccine Adsorbed, adjuvanted) under the Company’s existing contract with the Biomedical Advanced Research and Development Authority (BARDA).

Government 40

Government Vaccine Production Licensing 40

Codon

MARCH 3, 2024

Link Making Pan-Vaccines Current vaccines typically offer narrow protection against pathogens, such as influenza. As pathogens evolve and mutate, though, they can find ways to evade that protection, thus requiring that people get vaccinated repeatedly. Link Quadrivalent Influenza Vaccine. per kilo by 2030.

DNA 92

DNA Engineering Vaccine Virus 92

The Pharma Data

NOVEMBER 12, 2020

Comparing 2019 data with the historic low in reported measles cases in 2016, authors cite a failure to vaccinate children on time with two doses of measles-containing vaccines (MCV1 and MCV2) as the main driver of these increases in cases and deaths. “We MCV2 coverage has been steadily increasing but is only now at 71 percent.

Vaccine 52

Vaccine Virus Disease 52

Codon

OCTOBER 27, 2024

The second part — focused on vaccines and medicines — will be published next Sunday, concluding Issue 04 of Asimov Press. Identifying the bacteria behind the pathogen would later set the stage for many upcoming diagnostics, treatments, and even a vaccine. But doctors explored numerous uninformed remedies in the interim.

Immune Response 91

Immune Response Doctors Disease Laboratories 91

Codon

FEBRUARY 23, 2025

Because of PEPFAR’s effectiveness, the United Nations (UN) set an ambitious goal in 2022 to end HIV transmission and eliminate AIDS-related deaths by 2030. A lifelong HIV vaccine would be ideal, but developing one has proved difficult. billion worth of doses — equivalent to 200,000 vaccines.

Clinical Trials 68

Clinical Trials Virus Vaccine DNA 68